Today: 7 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Nike Stock Rises After Apple CEO Tim Cook Buys $3 Million Stake, Signaling Confidence in Turnaround Amid Tariffs and China Slowdown

Nike Stock Rises After Apple CEO Tim Cook Buys $3 Million Stake, Signaling Confidence in Turnaround Amid Tariffs and China Slowdown

Nike shares rose about 2% in premarket trading December 24 after an SEC filing showed Apple CEO Tim Cook bought 50,000 shares for nearly $3 million. Cook, Nike’s lead independent director, made the open-market purchase December 22 at an average price of $58.97. The move followed a post-earnings selloff and lifted sentiment despite ongoing concerns about Nike’s profitability and China sales.
24 December 2025
··
Eos Energy Enterprises Stock (EOSE) Turns Volatile After Chair Transition News as Wall Street Reprices the 2026 Ramp

Eos Energy Enterprises Stock (EOSE) Turns Volatile After Chair Transition News as Wall Street Reprices the 2026 Ramp

Eos Energy shares fell 7.21% to $11.96 on Dec. 23 after the company announced board chair Russ Stidolph will step down Dec. 31, with Joseph Nigro set to take over Jan. 1. The leadership change comes as trading volumes thin ahead of the early market close on Dec. 24, increasing volatility in the stock. Pre-market indications Wednesday showed modest gains.
24 December 2025
··
Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

Strategy Inc shares traded around $158 on December 24 after the company disclosed it sold 4.54 million shares for $747.8 million and paused Bitcoin purchases, keeping holdings steady. The firm’s U.S. dollar reserves rose to $2.19 billion, up from $1.44 billion earlier in December. Executive Chairman Michael Saylor is promoting a shift toward a broader capital markets platform.
24 December 2025
··
United States Antimony Corporation (UAMY) Stock: Today’s Move, Latest Contracts, Analyst Forecasts, and What Investors Are Watching on Dec. 24, 2025

United States Antimony Corporation (UAMY) Stock: Today’s Move, Latest Contracts, Analyst Forecasts, and What Investors Are Watching on Dec. 24, 2025

UAMY shares jumped 7.87% on Dec. 23, 2025, closing at $6.03 after trading in a wide range on heavy volume. Pre-market quotes on Dec. 24 showed the stock near $6.13. The company remains in focus as antimony draws attention as a critical mineral for defense and supply chains. UAMY’s recent contract wins and expansion plans have fueled volatility.
24 December 2025
·
AiRWA Inc (YYAI) Stock News, Forecasts and Analysis for Dec. 24, 2025: New 10‑Q, $15.69M Offering, and Why the Tape Is So Volatile

AiRWA Inc (YYAI) Stock News, Forecasts and Analysis for Dec. 24, 2025: New 10‑Q, $15.69M Offering, and Why the Tape Is So Volatile

AiRWA Inc. (NASDAQ: YYAI) announced a $15.69 million registered direct offering at $1.02 per share, matching the Dec. 18 close. Shares traded around $1.01 pre-market Dec. 24 after closing at $0.98 the prior session. The company, formerly Connexa Sports, recently rebranded and focuses on AI software for dating and Web3 tokenization. Proceeds target a joint venture and possible acquisitions.
24 December 2025
Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom shares traded near $350 on Dec. 24 amid thin holiday liquidity, following a volatile December driven by strong AI demand and margin concerns. The company projected Q1 revenue of $19.1 billion but warned of a 100 basis point gross margin drop due to lower-margin AI products. Broadcom reported a $73 billion backlog, mostly from five customers. U.S. delayed new China chip tariffs until 2027.
24 December 2025
··
Teva Stock News on Dec. 24, 2025: TEVA Rallies on S&P Credit Upgrade, $40 Price Target Hike, and Fresh Pipeline Catalysts

Teva Stock News on Dec. 24, 2025: TEVA Rallies on S&P Credit Upgrade, $40 Price Target Hike, and Fresh Pipeline Catalysts

Teva shares closed at $31.54 on Dec. 23, up 28% since Nov. 5, after S&P Global Ratings upgraded the company’s credit to ‘BB+’ on improved deleveraging. The stock traded near $31.93 pre-market Dec. 24. Analysts, including Piper Sandler, have raised price targets as Teva’s pipeline and biosimilars schedule gains clarity. Investors remain alert to pricing and patent risks.
24 December 2025
··
Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute shares remain under pressure after the company’s December 11, 2025, announcement that its pivotal sunRIZE Phase 3 trial for ersodetug in congenital hyperinsulinism failed to meet primary and key secondary endpoints. The stock trades near $2.42, well below pre-trial levels, following analyst downgrades and investor-law-firm probes. Two serious hypersensitivity reactions were reported in the trial.
24 December 2025
··
Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama shares closed near C$204.69 on December 24, 2025, as the S&P/TSX approached record highs in a shortened holiday session. The stock hit fresh highs after reporting Q3 sales up 22.2% to $1.91 billion and net earnings up 16.6% to $321.7 million. Investors are debating whether its premium valuation is justified as the company expands beyond its core market.
24 December 2025
··
Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals shares fell to $0.32 on December 24, 2025, after the FDA recommended a second Phase 3 trial for its schizophrenia drug brilaroxazine before a New Drug Application. The company said the new trial, RECOVER-2, could cost $60 million and delay potential approval to late 2028. Reviva plans to start the trial in the first half of 2026, pending financing.
24 December 2025
···
Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Regencell Bioscience Holdings (RGC) surged 14% to $25.25 on Dec. 24, 2025, despite remaining a pre-revenue company. The move followed a ValueWalk article highlighting RGC’s 17,000% gain in 2025, driven by low float, momentum trading, and a recent 38-for-1 stock split. Intraday prices ranged from $22.00 to $26.33. RGC’s market cap neared $11 billion.
24 December 2025
··
Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

The S&P 500 closed at a record 6,909.79 Tuesday, while U.S. stock futures edged lower early Wednesday ahead of a holiday-shortened session. A strong third-quarter GDP reading at 4.3% and persistent inflation are clouding the outlook for Federal Reserve rate cuts in 2026. The NYSE will close at 1 p.m. ET, with U.S. markets shut Thursday for Christmas. Key government data releases were delayed by a federal shutdown.
24 December 2025
Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth shares closed at $1.40 on Dec. 23, up 6.06%, after heavy trading and sharp swings throughout December. The volatility followed a Dec. 18 White House executive order directing marijuana rescheduling from Schedule I to III. Trading volume spiked to over 216 million shares on Dec. 18, with implied volatility near 143%. U.S. exchanges operated a shortened session on Dec. 24.
24 December 2025
····
Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics announced a $6 million preferred-stock financing with investor David Lazar, who will become chairman and co-CEO. The deal could add up to 111 million common shares if converted, pending shareholder approval. Shares jumped over 60% after hours on December 23, 2025, following the news, after closing at $1.95 in regular trading. Two directors resigned as part of the boardroom changes.
24 December 2025
··
Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next

Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next

Churchill Capital Corp X (NASDAQ: CCCX) surged nearly 10% to $17.27 on Dec. 23, 2025, and traded above $18 pre-market after Infleqtion’s chief scientist won the John Stewart Bell Prize. The rally is linked to renewed momentum around CCCX’s planned merger with Infleqtion, a quantum technology firm. CCCX remains a SPAC, with trading driven by sentiment and headlines.
24 December 2025
···
Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands shares traded near $10.53 on December 24, 2025, following sharp gains in the second half of the year. President Donald Trump signed an executive order on December 18 to begin the process of reclassifying marijuana from Schedule I to Schedule III. The move sparked volatility across cannabis stocks, with prices swinging as investors weighed the potential impact. The order does not legalize cannabis but directs federal agencies to review its status.
24 December 2025
··
Sable Offshore Corp (SOC) Stock News Today: PHMSA Clears Las Flores Pipeline Restart — Latest Price, Forecasts, and What Comes Next (Dec. 24, 2025)

Sable Offshore Corp (SOC) Stock News Today: PHMSA Clears Las Flores Pipeline Restart — Latest Price, Forecasts, and What Comes Next (Dec. 24, 2025)

The U.S. Pipeline and Hazardous Materials Safety Administration approved Sable Offshore Corp.’s plan to restart the Las Flores Pipeline System in California, according to a December 22 letter disclosed in an SEC filing. SOC shares surged 36% to $10.36 on December 23 and held those gains in early trading December 24. The pipelines, formerly Plains Line 901 and 903, have been at the center of a years-long dispute.
24 December 2025
··
1 … 385 386 387 388 389 … 588

Stock Market Today

  • Foreign Investors Sell Sh10bn in Top Nairobi Stocks as Dividends Rise
    June 7, 2026, 12:59 PM EDT. Foreign investors sold a net Sh10.17 billion worth of shares in Kenya's top five firms at the Nairobi Securities Exchange (NSE) by April 2026, including Safaricom, Equity Group, KCB Group, EABL, and Co-operative Bank. These seniors capitalised on significant price rallies, such as Safaricom's 69% rise to Sh29.70 and KCB's 74% gain. The sell-offs were mainly absorbed by local institutional investors, who raised stakes amid increased full-year dividends. Overall, foreign net outflows reached Sh17.4 billion, reflecting reallocations due to rising inflation and market risks. This activity highlights a shift towards domestic holders favouring stable dividend payouts over short-term gains, as noted by Standard Investment Bank analyst Melodie Ndanu.

Latest articles

Archer Aviation Sinks 13%. Two Big Tests Coming Next Week

Archer Aviation Sinks 13%. Two Big Tests Coming Next Week

7 June 2026
Archer Aviation plunged 13.2% to $5.54 Friday as investors dumped growth stocks after a strong May jobs report fueled fears of prolonged Fed rate hikes; with Archer still pre-revenue and burning cash, higher rates threaten future profit valuations and could keep pressure on the stock, especially if flight testing or FAA certification slows.
POET Technologies Stock Drops Sharply as Investors Watch

POET Technologies Stock Just Took a Hit — Why Monday Could Decide the Next Move

7 June 2026
POET Technologies plunged 23.36% to $11.86 Friday, ending the week 3.5% lower and well below its recent $21 financing price, as investors dumped AI and semiconductor stocks amid sector-wide selling and macro fears ahead of key U.S. inflation data, leaving POET’s outlook highly sensitive to customer orders and manufacturing execution.
Warner Bros. Discovery Move on Watch for Monday as Market Eyes Next Step

Warner Bros. Discovery Move on Watch for Monday as Market Eyes Next Step

7 June 2026
Warner Bros. Discovery shares fell 2.81% to $26.24 after reports that California, New York, and other states are preparing an antitrust lawsuit to block Paramount’s $110 billion takeover, increasing risk that the deal could be delayed or fail; the stock trades well below Paramount’s $31-a-share offer, reflecting investor doubts ahead of key U.S. and EU regulatory decisions.
Apple Stock’s Next Big Move May Come Monday As WWDC Puts Siri On Trial

Apple Stock’s Next Big Move May Come Monday As WWDC Puts Siri On Trial

7 June 2026
Apple shares slipped 1.5% last week to $307.34 as investors brace for Monday’s WWDC, where Apple must unveil a credible AI strategy—especially a more capable Siri—to regain confidence, with options traders pricing a 3% stock swing and analysts warning that only major surprises could lift the stock amid broader tech market volatility.
Redwire Shares Sink Despite Space Strawberry News

Redwire Shares Sink Despite Space Strawberry News

7 June 2026
Redwire Corp. plunged 25% this week, closing at $18.45 after Jefferies cut its rating to Hold, citing “limited near-term upside” despite a raised price target; trading was volatile following a new space-agriculture contract and amid a broad selloff in speculative space stocks as investors question if recent contract wins can support the stock’s run ahead of earnings.
Go toTop